During the Metronomic@Mumbai2016, Pr David Waxman, Prof. of Cell and Molecular Biology, Boston University, USA, gave an interview to ETHealthworld to tell them about the major advancements made in the field of metronomic chemotherapy more specifically about his work on the impact of metronomic chemotherapy on the immune system and the importance of (...)
In the Health Affair Blog, Vikas Sukhatme, Kathy Fang, Andrew Lo, and Vidula Sukhatme from Harvard and the MIT have posted a very interesting note entitled : Financial Orphan Therapies Looking For Adoption where they introduce the concept of «financial orphans drugs.» The authors first review briefly the process of drug development today and its relatd (...)
The International Symposium on Pediatric Neuro-Oncology (ISPNO) is the major biennial global meeting of the multi-disciplinary international community of professionals involved in the scientific research, diagnosis, treatment, rehabilitation of infants, children and young people with CNS tumors. The ISPNO took place Friday, June 29 to Tuesday, July 3, (...)
Following our[ Lancet Oncology] paper, metronomics is gaining interest in India where journals like The Economic Time and Times of India have recently highlighted the potential of metronomics ! Here are some examples: Cancer medicines for as low as Rs 1,000 a month on way ! MUMBAI: It’s widely known that a month’s dose of cancer drugs can cost lakhs, (...)
Following the Metronomic@Mumbai2016 meeting, Pr S. Banavali has been interviewed by ETWorldHeatlh.com. You can asses read his interview here Dr Shripad D. Banavali, Prof. and Head, Dept. of Medical & Pediatric Oncology, Tata Memorial Hospital, Mumbai, talks to ETHealthworld about the growing burden of cancer and changes that need to be made in (...)
Thanks to the help of Dr Bishal Gyawali, the Metronomics Global Health Initiative has now a facebook page. He will be in charge of the Facebook page. All the news will now be posted on both Facebook and the website. Here is the link to our facebookpage. Enjoy ! (function(d, s, id) var js, fjs = d.getElementsByTagName(s)[0]; if (...)
In a very recent article, Jake Berstein, reporter at ProPublica, highlights and ilustrates the raising concern about how drugs that are further investigated as potential cancer agents are chosen and therefore more specificaly why the cheep drug are hardly ever chosen. Starting with the story of Michael Retsky (a MGHI amabassador), who pionnered the use (...)
On the 10th July 2014 – New York, Pr Tezer Kutluk, paediatric oncologist, made the following opening speech at the UN General Assembly (UNGA) High-Level Meeting on the comprehensive review and assessment of the progress achieved in the prevention and control of non-communicable diseases Prof Tezer Kutluk has been recently invited by the General Assembly (...)
Research and Development to Meet Health Needs in Developing Countries: Strengthening Global Financing and Coordination Report of the Consultative Expert Working Group on Research and Development: Financing and Coordination New incentives needed to encourage health research and development for developing countries Funding needed to stimulate health (...)